Tamsulosin and Dementia in old age: is there any relationship?

Tamsulosin and Dementia in old age: is there any relationship?

Tamsulosin is used to treat Benign Prostatic Hyperplasia (BPH), prescribed annually to about 12.6 million patients worldwide. It is an alpha-adrenergic antagonist that reduces the tone of the prostate smooth muscle involved in the pathophysiology of BPH. By acting on alpha 1A receptors, predominant...

Full description

Bibliographic Details
Main Author:	Rebecca Renata Lapenda do Monte, Karina de Andrade Vidal Costa, Arnaldo Santiago Nunes Junior, Am lia Cinthia Meneses R go, Irami Ara jo Filho
Format:	Article
Language:	English
Published:	Bulgarian Association of Young Surgeons 2019-10-01
Series:	International Journal of Medical Reviews and Case Reports
Subjects:	benign prostatic hyperplasia prostatic hyperplasia cognitive functions tamsulosin dementia adrenergic alpha-1 receptor antagonists
Online Access:	http://www.mdpub.net/index.php?fulltxt=62889&fulltxtj=172&fulltxtp=172-1566846841.pdf

Similar Items

Short-term effect of tamsulosin and finasteride monotherapy and their combination on nigerian men with benign prostatic hyperplasia
by: Benjamin O Odusanya, et al.
Published: (2017-01-01)

Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia
by: Mahavir Singh Griwan, et al.
Published: (2014-01-01)

EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
by: Farhan Khan, et al.
Published: (2021-08-01)

Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride
by: Hassan El-Tatawy, et al.
Published: (2015-09-01)

Efficacy and safety of tamsulosin hydrochloride 0.2 mg and combination of tamsulosin hydrochloride 0.2 mg plus solifenacin succinate 5 mg after transurethral resection of the prostate: a prospective, randomized controlled trial
by: Shin YS, et al.
Published: (2016-09-01)

The Effect of Combined Therapy with Tamsulosin Hydrochloride and Meloxicam in Patients with Benign Prostatic Hyperplasia Symptoms and Impact on Nocturia and Sleep Quality
by: Sacit Nuri Gorgel, et al.
Published: (2013-09-01)

The Effect of Oral Tamsulosin vs. Oral Tamsulosin and Oral Isosorbide Dinitrate in Acute Urinary Retention Patients Due to Benign Prostatic Hyperplasia: A Double-Blind Clinical Trial Study
by: Iraj Golikhatir, et al.
Published: (2020-06-01)

Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia
by: Zhongbao Zhou, et al.
Published: (2019-03-01)

The prostatic urethral angle can predict the response to alpha adrenoceptor antagonist monotherapy for treating nocturia in men with lower urinary tract symptom: A multicenter study
by: Byung Hoon Kim, et al.
Published: (2016-03-01)

Predictive value of the immediate effect of first dose of tamsulosin on lower urinary tract symptoms improvement in benign prostatic hyperplasia patients
by: Ayman Salah Moussa, et al.
Published: (2019-01-01)

Relation of baseline prostate volume to improvement of lower urinary tract symptoms due to tamsulosin monotherapy in benign prostatic hyperplasia: An exploratory, multicenter, prospective study
by: Mahmoud Shoukry El-Adawy, et al.
Published: (2020-01-01)

Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients
by: Su Jin Kim, et al.
Published: (2017-03-01)

EFFECTIVENESS AND SAFETY OF THE «DE ALEX» BIO COMPLEX AS MONOTHERAPY AND IN COMBINATION WITH TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: P. A. Scheplev, et al.
Published: (2017-11-01)

PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA
by: N. A. Avxentyev, et al.
Published: (2016-09-01)

Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate
by: J Miller, et al.
Published: (2009-06-01)

Early versus late trail of catheter removal in patients with urinary retention secondary to benign prostatic hyperplasia under tamsulosin treatment
by: Salem Hassan Salem Mohamed, et al.
Published: (2018-01-01)

Combination therapy in patients with benign prostatic hyperplasia
by: Bojan Tršinar
Published: (2006-11-01)

COMPARISON OF EFFECTIVENESS OF MELOXICAM 15 MG ONLY, COMBINATION OF MELOXICAM 15 MG AND TAMSULOSIN 0.4 MG, AND TAMSULOSIN 0.4 MG ONLY FOR SUCCESS OF TWOC IN BPH PATIENTS WITH FIRST EPISODE OF ACUTE URINARY RETENTION
by: Muhammad Asro Abdih Yasa, et al.
Published: (2018-01-01)

Implication of ultrasound bladder parameters on treatment response in patients with benign prostatic hyperplasia under medical management
by: Rajeev Thekumpadam Puthenveetil, et al.
Published: (2015-10-01)

ROLE OF COMBINED KETOCONAZOLE AND TAMSULOSIN IN SUCCESSFUL TRIAL OF VOIDING WITHOUT CATHETER (TWOC) IN PATIENTS WITH ACUTE URINARY RETENTION DUE TO BENIGN PROSTATIC OBSTRUCTION
by: Muhammad Asim, et al.
Published: (2020-12-01)

The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: an open-label preliminary study
by: Bannakij Lojanapiwat, et al.
Published: (2011-08-01)

Effects of prostatic inflammation on LUTS and alpha blocker treatment outcomes
by: Ha Na Lee, et al.
Published: (2014-06-01)

Comparison of meloxicam, tamsulosin and combination of both drugs with 16 Fr and 20 Fr catheter on trial without catheter successfulness in patients with benign prostatic hyperplasia
by: Hasroni Fathurrahman, et al.
Published: (2018-12-01)

The Effectiveness of Silodosin for Nocturnal Polyuria in Elderly Men With Benign Prostatic Hyperplasia: A Multicenter Study
by: Young Won Kim, et al.
Published: (2015-09-01)

The relation between baseline PSA and symptomatic progression in Egyptian BPH patients receiving tamsulosin monotherapy: an exploratory multicentric prospective study
by: Mahmoud S. El-Adawy, et al.
Published: (2019-12-01)

Effects of Tamsulosin Combined With Solifenacin on Lower Urinary Tract Symptoms: Evidence From a Systematic Review, Meta-Analysis, and Trial Sequential Analysis of Randomized Controlled Trials
by: Yuxuan Song, et al.
Published: (2020-05-01)

A randomized comparative study of tamsulosin vs placebo in the treatment of benign prostatic hyperplasia
by: N K Mohanty, et al.
Published: (2003-01-01)

Tadalafil 5 mg Alone or in Combination with Tamsulosin 0.4 mg for the Management of Men with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Prospective Observational Trial
by: Arcangelo Sebastianelli, et al.
Published: (2019-07-01)

Androgen receptor CAG polymorphism and the risk of benign prostatic hyperplasia in a Brazilian population
by: Vanderlei Biolchi, et al.
Published: (2012-06-01)

Recent advances in managing chronic prostatitis/chronic pelvic pain syndrome [version 1; referees: 2 approved]
by: Jaspreet Sandhu, et al.
Published: (2017-09-01)

Pharmacoeconomics expediency of application of the combined preparation of Vezomni in comparison with a combination of Tamsulosin and Solifenacin in the form of monopreparations
by: S. K. Zyryanov, et al.
Published: (2018-06-01)

Benign prostatic hyperplasia: clinical treatment can complicate cataract surgery
by: Fernando Facio, et al.
Published: (2010-10-01)

Giant prostatic hyperplasia: Case report and literature review
by: Oktay Üçer, et al.
Published: (2011-12-01)

QUALITY OF LIFE AFTER PROSTATECTOMY
by: Darko Laketić
Published: (2005-07-01)

Giant prostatic hyperplasia and its causes
by: Marius Anglickis, et al.
Published: (2020-04-01)

Prostate Artery Embolization: Treatment of Symptomatic Benign Prostatic Hyperplasia
by: Jin Ho Hwang, et al.
Published: (2019-07-01)

Fixed and separate combination of solifenacin and tamsulosin in urinary disorders associated with benign prostatic hyperplasia: a choice based on price and value comparison
by: A. G. Tolkushin, et al.
Published: (2019-08-01)

Any Correlation Between Prostate Volume and Incidence of Prostate Cancer: A Review of Reported Data for the Last Thirty Years
by: Yamashiro JR, et al.
Published: (2021-10-01)

A Prospective, Multicenter, Open-Label Study of Dose Escalation Therapy in Male Patients With Nocturia Refractory to 0.2-mg Tamsulosin Monotherapy
by: Ho Song Yu, et al.
Published: (2019-12-01)

SUCCESS RATES OF TAMSULOSIN AND DUTASTERIDE AS MEDICAL THERAPY BASED ON IPSS IN SYMPTOMATIC BPH PATIENTS IN ARIFIN ACHMAD HOSPITAL PEKANBARU RIAU
by: Zuhirman Zamzami
Published: (2018-07-01)